文献速递细菌感染、耐药与抗菌药物医院感染防控

耐利奈唑胺、替加环素和万古霉素屎肠球菌克隆播散

Clonal spread of linezolid-, tigecycline-, and vancomycin-resistant Enterococcus faecium isolates co-harbouring transferable optrA, vanA and tet(M) variant.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

本研究调查中国某医院外科ICU中3株同时耐利奈唑胺、替加环素和万古霉素的屎肠球菌(LTVRE)的克隆传播与分子基础。全基因组测序显示3株属于同一克隆(ST78),optrA与vanA共位于可转移的大型线性质粒(327.5 kb),tet(M)变体(F473I)位于Tn916样转座子且可水平转移。结果表明质粒与染色体移动元件独立或协同驱动耐药传播,需加强监测。

要点

  • 3株LTVRE属同一克隆ST78,提示ICU内克隆播散。
  • optrA与vanA共位于327.5 kb可转移线性质粒,介导利奈唑胺和万古霉素耐药。
  • tet(M)变体(F473I)位于Tn916样转座子,可水平转移并赋予替加环素耐药。

核心结论

  • 质粒携带与染色体移动遗传元件独立或协同驱动LTVRE对最后防线抗生素的耐药传播。
  • 需加强多重耐药屎肠球菌(如LTVRE)的监测。

研究设计与样本

  • 对某中国医院外科ICU患者中收集的3株LTVRE进行抗菌药物敏感性试验和全基因组测序分析。
  • 采用S1核酸酶脉冲场凝胶电泳验证质粒拓扑结构,并通过接合实验评估耐药决定簇的可转移性。

主要发现

  • 全基因组测序分析显示3株LTVRE属于同一克隆(序列型ST78)。
  • optrA和vanA基因共位于一个可转移的大型线性质粒(大小为327.5 kb),贡献利奈唑胺和万古霉素耐药。
  • 在Tn916样转座子内鉴定出携带第473位苯丙氨酸至异亮氨酸替换(F473I)的tet(M)变体,虽为染色体编码,但保留水平转移至屎肠球菌BM4105RF的能力并赋予替加环素耐药。

临床怎么用

  • 对ICU中多重耐药屎肠球菌应警惕质粒与染色体元件介导的耐药共传播,加强分子监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study investigated the clonal dissemination and molecular basis of linezolid-, tigecycline- and vancomycin-resistant E. faecium (LTVRE) isolates in a surgical intensive care unit (SICU) of a Chinese hospital. METHODS: Three LTVRE isolates collected from patients in the SICU were subjected to antimicrobial susceptibility testing and whole-genome sequencing analysis. S1 nuclease pulsed-field gel electrophoresis was performed to verify the topology of plasmids. Conjugation experiments were conducted to evaluate the transferability of resistance determinants. RESULTS: WGS analysis demonstrated that the three LTVRE belonged to the same clone (Sequence Type 78). The optrA and vanA genes were co-located on a transferable large linear plasmid (327.5 kb in size) and contributed resistance to linezolid and vancomycin. A tet(M) variant carrying a phenylalanine-to-isoleucine substitution at Position 473 (F473I) was identified within a Tn916-like transposon. Although chromosomally encoded, this element retains the capacity for horizontal transfer to E. faecium BM4105RF and conferred tigecycline resistance. CONCLUSIONS: Our findings reveal a resistance dissemination strategy in which plasmid-borne and chromosomal mobile genetic elements independently or cooperatively drive the spread of resistance to last-line antibiotics and highlight the urgent need for enhanced surveillance of multidrug-resistant E. faecium, such as LTVRE.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Zeng K, Shen W, Cai J, et al. Clonal spread of linezolid-, tigecycline-, and vancomycin-resistant Enterococcus faecium isolates co-harbouring transferable optrA, vanA and tet(M) variant. J Antimicrob Chemother. 2026. PMID: 42663137. doi:10.1093/jac/dkag292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。